ASML to 2035 still has a rare long-term strategic franchise, but the long-range stock outlook should be framed with explicit revenue, margin, and valuation assumptions rather than pure enthusiasm.

Eli Lilly still has a credible path to a materially larger business by 2030, but the stock is no longer cheap enough for optimism alone. The central question is whether obesity, diabetes, and pipeline ...

AI can help Airbus through manufacturing efficiency, services revenue and predictive maintenance, but it is not yet a stand-alone reason for a separate stock multiple.

ASML remains one of Europe's strongest AI and semiconductor capex franchises, but the 2027 stock range still depends on order conversion, export-control risk, and valuation discipline.

Tencent stock analysis for 2030 with current valuation, AI and WeChat drivers, bull-base-bear scenarios, and investor positioning.

Bullish drivers for Novartis based on current company data, valuation, sector context, and actionable scenarios.

Walmart in context: what the current price already assumes. Walmart closed at $132.46 on May 14, 2026. Over the last 10 years, adjusted monthly closes ran ...

Long-term 2030 outlook for HSBC Holdings using current price, 10-year history, official guidance, macro data and scenario ranges.

S&P 500 with valuation, earnings, inflation, scenario probabilities, trigger levels, and institutional data updated for mid-2026.

Bearish drivers for Novartis based on current data, valuation, sector breadth, and scenario-based downside conditions.

S&P 500 with valuation, earnings, inflation, scenario probabilities, trigger levels, and institutional data updated for mid-2026.

Eli Lilly can keep rising because the earnings engine is still accelerating, not because investors suddenly discovered the story. The stock only deserves another leg higher if raised 2026 guidance ...